FDA approves reslizumab to treat severe asthma – Pharmacy Today, American Pharmacists Association, pharmacist.com


Medscape

FDA approves reslizumab to treat severe asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com
FDA has cleared reslizumab (Cinqair—Teva) for use with other asthma medicines for the maintenance treatment of severe asthma in adults. The drug is indicated for patients with a history of severe asthma attacks despite using their current asthma …
FDA approves Cinqair to treat severe asthmaFDA.gov
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
FDA Approves Teva's Asthma Injection to Treat Severe AsthmaNews Every day
Globes –UPI.com
all 55 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.